Human OPG (TNFRSF11B) / Osteoprotegerin ELISA Kit PicoKine(r)

Name: Human OPG (TNFRSF11B) / Osteoprotegerin ELISA Kit PicoKine(r)
SKU: EK0480_1X96WELLPLATE_B70
Availability: BackOrder

EK0480

ReactivityHuman

Product group Assays

Overview

Supplier
Boster Bio
Product Name
Human OPG (TNFRSF11B) / Osteoprotegerin ELISA Kit PicoKine(r)
Delivery Days Customer
9
Applications
ELISA
Applications Supplier
ELI
Assay Detection Range
93.7 pg/ml - 6,000 pg/ml
Assay Sensitivity
<5 pg/ml
Assay Time
15-20
Certification
Research Use Only
Scientific Description
Human OPG (TNFRSF11B) / Osteoprotegerin ELISA Kit PicoKine® (96 Tests). Quantitate Human TNFRSF11B in cell culture supernatants, serum, plasma (heparin, EDTA) , saliva and urine. Sensitivity: 5pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
Reactivity
Human
Reactivity Supplier
Human OPG
Storage Instruction
-20°C,2°C to 8°C
UNSPSC
41116158

References

Zhang D, Xu C, Zhang J, et al. Plasma TNFRSF11B as a New Predictive Inflammatory Marker of Sepsis-ARDS with Endothelial Dysfunction. J Proteome Res. 2023,22(11):3640-3651. doi: 10.1021/acs.jproteome.3c00576
Read this paper
Elshamy AM, Hafez YM, Safa MAE, et al. The role of miR-433-3p in vascular calcification in type 2 diabetic patients: targeting WNT/β-Catenin and RANKL/RANK/OPG signaling pathways. Mol Biol Rep. 2023,50(11):9073-9083. doi: 10.1007/s11033-023-08792-9
Read this paper
Li Y, Yang S. Rb1 negatively regulates bone formation and remodeling through inhibiting transcriptional regulation of YAP in Glut1 and OPG expression and glucose metabolism in male mice. Mol Metab. 2022,66:101630. doi: 10.1016/j.molmet.2022.101630
Read this paper
Pingali U, Nutalapati C. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial. Phytomedicine. 2022,105:154334. doi: 10.1016/j.phymed.2022.154334
Read this paper
Ma W, Jin W, He X, et al. Mycobacterium tuberculosis Induced Osteoblast Dysregulation Involved in Bone Destruction in Spinal Tuberculosis. Front Cell Infect Microbiol. 2022,12:780272. doi: 10.3389/fcimb.2022.780272
Read this paper
Bozkurt Doğan Ş, Öngöz Dede F, Ballı U, et al. Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease. Cytokine. 2021,144:155584. doi: 10.1016/j.cyto.2021.155584
Read this paper
Bonaccorsi G, Trentini A, Greco P, et al. Changes in Adipose Tissue Distribution and Association between Uric Acid and Bone Health during Menopause Transition. Int J Mol Sci. 2019,20(24). doi: 10.3390/ijms20246321
Read this paper
Liu S, Luo ZH, Ji GM, et al. Cajanolactone A from Cajanus cajan Promoted Osteoblast Differentiation in Human Bone Marrow Mesenchymal Stem Cells via Stimulating Wnt/LRP5/β-Catenin Signaling. Molecules. 2019,24(2). doi: 10.3390/molecules24020271
Read this paper
Huang YZ, He SK, Guo ZJ, et al. Nanostructured titanium surfaces fabricated by hydrothermal method: Influence of alkali conditions on the osteogenic performance of implants. Mater Sci Eng C Mater Biol Appl. 2019,94:1-10. doi: 10.1016/j.msec.2018.08.069
Read this paper
Zhang Q, Chen S, Shi J, et al. Coupled OPG-Fc on Decellularized Aortic Valves by EDC/NHS Attenuates Rat MSCs Calcification In Vitro. ASAIO J. 2019,65(2):197-204. doi: 10.1097/MAT.0000000000000796
Read this paper